The first biannual Performance Review Meeting for the year 2016 was a two-leg event, with two meetings held in Eldoret and Nyeri respectively. In both meetings, County health managers and other key partners working with the National Tuberculosis, Leprosy and Lung Disease Program (NTLD-Program) came together with the first leg hosting participants from 23 counties from the Western and Rift Valley regions, and the second leg hosting 24 counties drawn from the Northern, Coastal, Central and Nairobi regions. The main objective of these meetings is to help County TB and Leprosy Coordinators from all the Counties share their progress reports as well as validate data collected over the previous period. Such data includes: TB/HIV outcomes, Isoniazid Preventive Therapy (IPT) initiation progress, lab and commodity status, as well as trainings offered. The meetings also provide a platform to review case finding and outcomes of TB control activities as well as share experiences, challenges and best practices.
In his opening remarks at the beginning of the first leg of these meetings in Eldoret, the Uasin Gishu County TLC Dr Hillary Ndiema acknowledged that Uasin Gishu County had received tremendous support from the NTLD-Program in the fight against TB.
During the second leg of the meeting in Nyeri, the opening remarks from Nyeri County TLC Dr Hiram Mathenge, noted that Nyeri County has managed to achieve 100% HIV testing for all TB cases; a huge milestone as this was a rare practice in the past.
The two-leg meetings conducted over a ten-day period successfully adjourned on May 13, 2016 with remarks from the NTLD-Program Head Dr Enos Masini. Dr Masini urged all officials to work with County Governments and partners to strengthen TB eradication activities and to support the provision of funds to help in strengthening TB activities across the country. Among the action points agreed on going forward, was that the number of TB cases initiated on IPT must increase by 50% by 30th June and 90% by 31st December 2016. Another was that geneXpert should be the initial test for TB but smears should be used as a follow up test for the disease to ensure that it is fully cured. Also of great concern was to increase diagnosis of child TB in counties to ensure there are no missed cases of Child TB. Both meetings were supported by the USAID funded Tuberculosis Accelerated Response and Care (TB ARC) activity.